SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-024096
Filing Date
2021-04-01
Accepted
2021-04-01 16:17:10
Documents
2
Period of Report
2021-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1530
2 POA DOCUMENT poa.txt EX-24.3_976593 3957
  Complete submission text file 0001209191-21-024096.txt   6825
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Bergstrom Donald A (Reporting) CIK: 0001709772 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 21798218

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences